K Lesli Ligorner

Lesli leads the labor and employment practice in mainland China and handles cross-border employment matters and internal investigations across the Asia-Pacific region. She advises on global mobility and immigration, leaves of absence, wage and hour laws, intellectual property protection, and unionization and collective bargaining.

Lesli’s practice further includes compliance counseling and training covering establishment and enforcement of company policies, the Foreign Corrupt Practices Act (FCPA) and local anticorruption compliance, export controls, data protection and cybersecurity issues, and employment and anticorruption due diligence in mergers and acquisitions and related internal investigations.

Employment

• Advising on pre-acquisition due diligence employment risks and liabilities and post-acquisition rectification strategies and risk mitigation for US-listed technology client in Guangdong Province, including social insurance underpayment, housing fund underpayment and non-enrollment, underpaid and incorrectly managed overtime, unlicensed dormitory and canteen, underage employees, shadow employees, unlawful labor dispatch practices and immigration irregularities
• Advising clients on strategic employment and compensation structures to meet regulatory requirements, achieve compensation goals and minimize permanent establishment risks
• Advising global investment banks on unionization and collective bargaining strategies in China
• Advising a global technology client with respect to post-termination restrictive covenants across 13 jurisdictions in APAC
• Advising on employment risks related to nonrenewal of US-listed telecommunications manufacturing client’s contract with outsourced equipment manufacturer while seeking to retain the employees for newly commencing contract in same location
• Preparing strategy for handling factory-wide claims of unpaid social benefits, underpaid overtime and other employment-related noncompliance in connection with significant restructuring exercise, resulting in no work disruptions
• Supervising the liquidation of a financial services company’s subsidiaries in Tianjin, Beijing and Shanghai and coordinating termination plan and documentation
• Preparing and conducting workplace training for China workforce regarding working hours and overtime issues, performance management, and general respect in the workplace
• Advising US-listed technology company on termination strategy and documentation for dismissal of multiple senior executives due to violations of company’s revenue recognition, channel management and anti-bribery policies
• Reviewing evidence from FCPA investigation and preparing strategy and coordinating disciplinary actions for 30+ employees in Chinese subsidiary of technology client, resulting in resignation of key wrongdoers

Investigations

• Leading investigation for global medical device manufacturer into allegations of self-dealing, bribery and corruption at China subsidiary
• Conducting investigation into 35+ transactions by Chinese subsidiary of US-listed life sciences company involving sales of instruments to government agencies, involving third parties placed on Entity List during investigation
• Coordinating investigation into expense reimbursement fraud by country manager and his assistant for US-listed audio equipment manufacturer’s Philippine’s subsidiary and assisting with post-investigation employment proceedings
• Supervising internal investigation concurrent with managing regulator’s investigation of whistleblower’s allegations of alleged trademark infringement by sole distributor and sub-distributor for European company’s government infrastructure business in China
• Conducting investigation into bribery allegations around regulatory approvals by US-listed life sciences company’s personnel in China
• Leading investigation into manipulation of sales and revenue recognition practices by Japanese management at subsidiary of US-listed technology company
• Supervising an investigation for US-listed medical device manufacturer into allegations reported by Chinese regulator regarding alleged corruption with respect to lab approvals for new medical devices
• Leading US-driven regulatory investigation into Chinese technology company’s alleged failure to take employment actions that were stipulated and agreed with US government agency
• Supervising an investigation into manipulation of revenue recognition policy for US-listed medical device company’s subsidiary in Japan and ensuing disciplinary hearings for multiple employees
• Conducting an investigation into sexual harassment and bribery allegations against a senior executive at a US-listed biotechnology company’s subsidiary in China
• Leading a cross-border investigation into allegations of commercial bribery and trade secret theft in Germany for a listed Chinese technology company, which findings were reported to the public prosecutor
• Leading an investigation into corruption at a US-listed medical device manufacturer’s subsidiary in China and advising on employment aspects with respect to off-books wage payments, individual income tax exposure, policy rollout and training, and management of dawn raid

Results may vary depending on your particular facts and legal circumstances.